Nematode Infections: Clinical Trials

3 trials for Nematode Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 21Unknown 1

Follow Nematode Infections: new trials by email Literature Review of Nematode Infections trials Research Report on Nematode Infections

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases
Phase 3UnknownLondon School of Hygiene and Tropical Medicine240002021-05-032022-02-24
Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Albendazole, Placebo - Toxocariasis
Phase 3UnknownHospital de Niños R. Gutierrez de Buenos Aires452008-09-012023-03-02

Narrower conditions

Ancylostomiasis (1)  ·  Elephantiasis, Filarial (1)  ·  Eosinophilia (1)  ·  Filariasis (1)  ·  Loiasis (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Neglected Diseases (1)  ·  Onchocerciasis (1)  ·  Scabies (1)  ·  Strongyloidiasis (1)  ·  Toxocariasis (1)

Broader conditions

Helminthiasis (3)  ·  Infections (3)  ·  Parasitic Diseases (3)  ·  Secernentea Infections (3)  ·  Hemic and Lymphatic Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)  ·  Skin Diseases, Parasitic (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Spirurida Infections (2)  ·  Animal Diseases (1)  ·  Ascaridida Infections (1)  ·  Disease Attributes (1)  ·  Ectoparasitic Infestations (1)

Interventions

Albendazole (1)  ·  Ivermectin (1)  ·  Levamisole (1)

Sponsors

Hospital de Niños R. Gutierrez de Buenos Aires (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Programme National de Lutte contre l'Onchocercose, Republic of the Congo (1)

Countries

Argentina (1)  ·  Guinea-Bissau (1)  ·  Republic of the Congo (1)

Top investigators

Anna R Last, MBChB PhD (1)  ·  Hector Freilij, MD (1)  ·  Jaime Altcheh, MD (1)

Results publications

PMID 37419638, PMID 39551062, PMID 40615414